OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma
Johannes Tobias Thiel, Adrien Daigeler, Jonas Kolbenschlag, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3380-3380
Open Access | Times Cited: 10

Showing 10 citing articles:

Cyclers’ kinases in cell division: from molecules to cancer therapy
Giacomo Milletti, Valeria Colicchia, Francesco Cecconi
Cell Death and Differentiation (2023) Vol. 30, Iss. 9, pp. 2035-2052
Open Access | Times Cited: 11

Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation
Noha H. Amin, Mohammed T. El‐Saadi, Maha M. Abdel‐Fattah, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106496-106496
Closed Access | Times Cited: 7

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies
Ted Kim, Nam Q. Bui
Cancers (2023) Vol. 15, Iss. 6, pp. 1692-1692
Open Access | Times Cited: 3

Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
Alessandra Merlini, Valeria Pavese, Giulia Manessi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2

The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1647-1647
Open Access | Times Cited: 1

Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer
Surya K. De
Current Medicinal Chemistry (2023) Vol. 31, Iss. 8, pp. 1040-1043
Closed Access | Times Cited: 1

The significance of quinazoline derivatives as potential multi-target anti-cancer agents: review article
Mostafa A. Mansour, Samar H. Abbas, Asma AboulMagd, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 1-17
Open Access | Times Cited: 1

Page 1

Scroll to top